The Risk Factors for the Wearing-off Phenomenon in Parkinson's Disease in Japan: A Cross-sectional, Multicenter Study-Reference-Cited by-同舟云学术

The Risk Factors for the Wearing-off Phenomenon in Parkinson's Disease in Japan: A Cross-sectional, Multicenter Study

Published:2017 Issue:15 Volume:56 Page:1961-1966
ISSN:0918-2918
Container-title:Internal Medicine
language:en
Short-container-title:Intern. Med.

Author:

Ouma Shinji¹,Fukae Jiro¹,Fujioka Shinsuke¹,Yamamoto Shosaburo¹,Hatano Taku²,Yoritaka Asako³,Okuma Yasuyuki⁴,Kashihara Ken-ichi⁵,Hattori Nobutaka²,Tsuboi Yoshio¹

Affiliation:

1. Department of Neurology, Fukuoka University School of Medicine, Japan

2. Department of Neurology, Juntendo University School of Medicine, Japan

3. Department of Neurology, Juntendo Koshigaya Hospital, Japan

4. Department of Neurology, Juntendo Shizuoka Hospital, Japan

5. Department of Neurology, Okayama Kyokuto Hospital, Japan

Publisher

Japanese Society of Internal Medicine

Subject

General Medicine,Internal Medicine

Link

https://www.jstage.jst.go.jp/article/internalmedicine/56/15/56_56.7667/_pdf

Reference22 articles.

1. 1. Kalia LV, Lang AE. Parkinson's disease. Lancet 386: 896-912, 2015.

2. 2. Seki M, Takahashi K, Uematsu D, et al. Clinical features and varieties of non-motor fluctuations in Parkinson's disease: a Japanese multicenter study. Parkinsonism Relat Disord 19: 104-108, 2013.

3. 3. Schrag A, Quinn N. Dyskinesias and motor fluctuations in Parkinson's disease. A community-based study. Brain 123: 2297-2305, 2000.

4. 4. Ahlskog JE, Muenter MD. Frequency of levodopa-related dyskinesias and motor fluctuations as estimated from the cumulative literature. Mov Disord 16: 448-458, 2001.

5. 5. Stocchi F, Antonini A, Barone P, et al; DEEP study group. Early DEtection of wEaring off in Parkinson disease: the DEEP study. Parkinsonism Relat Disord 20: 204-211, 2014.

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cost-effectiveness Analysis of COMT-inhibitors as Adjuvant Treatments to Levodopa in Patients with Advanced Parkinson's Disease;Clinical Therapeutics;2024-09

2. Tolperisone hydrochloride improves motor functions in Parkinson’s disease via MMP-9 inhibition and by downregulating p38 MAPK and ERK1/2 signaling cascade;Biomedicine & Pharmacotherapy;2024-05

3. Association of Depression With Early Occurrence of Postural Instability in Parkinson’s Disease;Journal of Movement Disorders;2023-01-31

4. (63) A Differential for Lack of Spontaneous Movement: A Case of Akinesia from on-off Phenomena in Parkinson's Disease being Confused with Catatonia;Journal of the Academy of Consultation-Liaison Psychiatry;2022-11

5. Development of Prodrugs for Treatment of Parkinson‘s Disease: New Inorganic Scaffolds for Blood–Brain Barrier Permeation;Journal of Pharmaceutical Sciences;2022-05